| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medulloblastoma | 33 | 2025 | 388 | 6.000 |
Why?
|
| Cerebellar Neoplasms | 26 | 2025 | 323 | 4.680 |
Why?
|
| Ependymoma | 9 | 2024 | 154 | 2.550 |
Why?
|
| Neoplastic Stem Cells | 15 | 2025 | 329 | 2.200 |
Why?
|
| Brain Neoplasms | 17 | 2025 | 1314 | 1.560 |
Why?
|
| Gene Expression Regulation, Neoplastic | 22 | 2025 | 2018 | 1.500 |
Why?
|
| Hedgehog Proteins | 9 | 2025 | 203 | 0.990 |
Why?
|
| Transcriptome | 9 | 2025 | 1132 | 0.920 |
Why?
|
| Infratentorial Neoplasms | 4 | 2024 | 37 | 0.830 |
Why?
|
| Glioblastoma | 6 | 2024 | 357 | 0.700 |
Why?
|
| Neoplasm Metastasis | 4 | 2020 | 701 | 0.640 |
Why?
|
| Metencephalon | 3 | 2025 | 11 | 0.630 |
Why?
|
| Cerebrospinal Fluid | 1 | 2020 | 100 | 0.620 |
Why?
|
| Biomarkers, Tumor | 8 | 2025 | 1603 | 0.600 |
Why?
|
| Cancer Vaccines | 1 | 2020 | 190 | 0.560 |
Why?
|
| Otx Transcription Factors | 4 | 2024 | 26 | 0.560 |
Why?
|
| Genomics | 7 | 2025 | 1622 | 0.550 |
Why?
|
| Molecular Targeted Therapy | 5 | 2019 | 381 | 0.540 |
Why?
|
| DNA Copy Number Variations | 5 | 2025 | 1027 | 0.520 |
Why?
|
| Mice | 23 | 2025 | 18224 | 0.490 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2024 | 988 | 0.470 |
Why?
|
| Transcription Factors | 2 | 2025 | 2440 | 0.470 |
Why?
|
| Evolution, Molecular | 1 | 2019 | 656 | 0.470 |
Why?
|
| Fetus | 1 | 2019 | 584 | 0.460 |
Why?
|
| Single-Cell Analysis | 7 | 2025 | 360 | 0.460 |
Why?
|
| Animals | 30 | 2025 | 33899 | 0.450 |
Why?
|
| Transcription, Genetic | 2 | 2019 | 1382 | 0.450 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2017 | 210 | 0.440 |
Why?
|
| Spinal Neoplasms | 1 | 2015 | 75 | 0.430 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2025 | 1268 | 0.420 |
Why?
|
| Cell Proliferation | 15 | 2025 | 2468 | 0.420 |
Why?
|
| Cell Differentiation | 7 | 2025 | 1921 | 0.420 |
Why?
|
| Gene Expression Profiling | 12 | 2025 | 1843 | 0.410 |
Why?
|
| Rhombencephalon | 2 | 2024 | 68 | 0.410 |
Why?
|
| Meningeal Neoplasms | 2 | 2025 | 210 | 0.380 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 949 | 0.380 |
Why?
|
| Cell Lineage | 4 | 2024 | 346 | 0.370 |
Why?
|
| Humans | 55 | 2025 | 130574 | 0.360 |
Why?
|
| Clonal Evolution | 1 | 2012 | 46 | 0.360 |
Why?
|
| Cell Line, Tumor | 10 | 2025 | 3702 | 0.350 |
Why?
|
| Neoplasm Proteins | 4 | 2019 | 673 | 0.340 |
Why?
|
| Neuroglia | 2 | 2019 | 222 | 0.330 |
Why?
|
| Consensus | 2 | 2016 | 528 | 0.320 |
Why?
|
| Stem Cells | 2 | 2024 | 711 | 0.310 |
Why?
|
| Signal Transduction | 12 | 2025 | 4665 | 0.300 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2025 | 815 | 0.290 |
Why?
|
| Cell Self Renewal | 2 | 2021 | 49 | 0.280 |
Why?
|
| DNA Methylation | 8 | 2024 | 1092 | 0.270 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2025 | 993 | 0.270 |
Why?
|
| Child | 18 | 2025 | 26145 | 0.260 |
Why?
|
| Mutation | 9 | 2025 | 6139 | 0.250 |
Why?
|
| Chromatin | 2 | 2021 | 501 | 0.250 |
Why?
|
| Glioma | 2 | 2022 | 504 | 0.240 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2025 | 27 | 0.230 |
Why?
|
| Radiation Tolerance | 1 | 2025 | 61 | 0.230 |
Why?
|
| Meninges | 1 | 2025 | 22 | 0.230 |
Why?
|
| Tumor Cells, Cultured | 4 | 2020 | 962 | 0.220 |
Why?
|
| Shab Potassium Channels | 1 | 2025 | 6 | 0.220 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2025 | 22 | 0.220 |
Why?
|
| Alternative Splicing | 2 | 2024 | 309 | 0.220 |
Why?
|
| Epigenesis, Genetic | 4 | 2018 | 771 | 0.220 |
Why?
|
| Stem Cell Niche | 1 | 2024 | 56 | 0.210 |
Why?
|
| Valproic Acid | 1 | 2025 | 155 | 0.210 |
Why?
|
| Precision Medicine | 2 | 2018 | 380 | 0.210 |
Why?
|
| Endothelial Cells | 2 | 2024 | 517 | 0.210 |
Why?
|
| Coculture Techniques | 1 | 2024 | 232 | 0.200 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2015 | 25 | 0.200 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 168 | 0.200 |
Why?
|
| Tumor Microenvironment | 2 | 2025 | 690 | 0.200 |
Why?
|
| Female | 22 | 2025 | 70509 | 0.200 |
Why?
|
| Prognosis | 7 | 2025 | 4927 | 0.200 |
Why?
|
| Immunity, Innate | 1 | 2025 | 410 | 0.190 |
Why?
|
| Child, Preschool | 10 | 2025 | 14987 | 0.190 |
Why?
|
| Cerebrum | 1 | 2022 | 34 | 0.180 |
Why?
|
| Histones | 4 | 2025 | 543 | 0.180 |
Why?
|
| Cerebellum | 3 | 2022 | 440 | 0.180 |
Why?
|
| Astrocytoma | 1 | 2022 | 105 | 0.180 |
Why?
|
| Congenital Abnormalities | 1 | 2025 | 321 | 0.180 |
Why?
|
| PAX3 Transcription Factor | 1 | 2020 | 29 | 0.160 |
Why?
|
| Injections, Intraventricular | 1 | 2020 | 53 | 0.160 |
Why?
|
| Male | 19 | 2025 | 64557 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 2 | 2024 | 418 | 0.160 |
Why?
|
| MicroRNAs | 3 | 2018 | 901 | 0.160 |
Why?
|
| Genome, Human | 5 | 2024 | 1323 | 0.160 |
Why?
|
| RNA, Small Nuclear | 1 | 2019 | 49 | 0.150 |
Why?
|
| Clone Cells | 2 | 2017 | 152 | 0.150 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 213 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 239 | 0.140 |
Why?
|
| Infant | 7 | 2025 | 13306 | 0.140 |
Why?
|
| Gene Regulatory Networks | 4 | 2025 | 380 | 0.140 |
Why?
|
| Epigenomics | 2 | 2020 | 183 | 0.140 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2018 | 15 | 0.140 |
Why?
|
| Neuroectodermal Tumors | 1 | 2018 | 12 | 0.140 |
Why?
|
| Telomerase | 1 | 2018 | 155 | 0.140 |
Why?
|
| Cell Tracking | 1 | 2017 | 15 | 0.130 |
Why?
|
| Rhabdoid Tumor | 1 | 2018 | 48 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 240 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2020 | 813 | 0.130 |
Why?
|
| Carcinogenesis | 1 | 2020 | 349 | 0.130 |
Why?
|
| Teratoma | 1 | 2018 | 122 | 0.120 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1053 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 253 | 0.120 |
Why?
|
| Adult | 11 | 2022 | 31202 | 0.120 |
Why?
|
| Genetic Heterogeneity | 3 | 2025 | 133 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 604 | 0.120 |
Why?
|
| CpG Islands | 2 | 2018 | 339 | 0.120 |
Why?
|
| Hexokinase | 1 | 2015 | 25 | 0.110 |
Why?
|
| Selection, Genetic | 1 | 2016 | 156 | 0.110 |
Why?
|
| Disease Models, Animal | 5 | 2025 | 4664 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 1213 | 0.110 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 121 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2018 | 1090 | 0.110 |
Why?
|
| Neurogenesis | 3 | 2024 | 220 | 0.110 |
Why?
|
| Mice, SCID | 3 | 2025 | 580 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 90 | 0.110 |
Why?
|
| Neoplasms | 2 | 2025 | 2951 | 0.110 |
Why?
|
| Neurons | 1 | 2024 | 2007 | 0.110 |
Why?
|
| Young Adult | 5 | 2025 | 9991 | 0.100 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2014 | 55 | 0.100 |
Why?
|
| Adolescent | 8 | 2025 | 20774 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 54 | 0.100 |
Why?
|
| Time Factors | 3 | 2019 | 6223 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2015 | 264 | 0.100 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 1841 | 0.100 |
Why?
|
| Genes, Neoplasm | 2 | 2010 | 80 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 91 | 0.100 |
Why?
|
| Carrier Proteins | 1 | 2018 | 1017 | 0.100 |
Why?
|
| Cell Movement | 3 | 2024 | 868 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2015 | 1948 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1124 | 0.090 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 153 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2017 | 715 | 0.090 |
Why?
|
| Heart Function Tests | 1 | 2011 | 49 | 0.090 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2012 | 50 | 0.090 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2012 | 110 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1694 | 0.090 |
Why?
|
| Genes, p53 | 1 | 2012 | 211 | 0.090 |
Why?
|
| Mice, Transgenic | 4 | 2019 | 2340 | 0.090 |
Why?
|
| Mutagenesis, Insertional | 1 | 2012 | 151 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2011 | 109 | 0.090 |
Why?
|
| Genetic Testing | 1 | 2018 | 1087 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 2012 | 182 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2011 | 195 | 0.080 |
Why?
|
| Cell Survival | 2 | 2025 | 840 | 0.080 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 373 | 0.080 |
Why?
|
| International Cooperation | 1 | 2010 | 156 | 0.080 |
Why?
|
| Genetics, Medical | 1 | 2010 | 120 | 0.070 |
Why?
|
| Anilides | 2 | 2019 | 51 | 0.070 |
Why?
|
| Pediatrics | 1 | 2018 | 1241 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 542 | 0.070 |
Why?
|
| Smoothened Receptor | 2 | 2019 | 31 | 0.070 |
Why?
|
| Pyridines | 2 | 2019 | 258 | 0.070 |
Why?
|
| Survival Rate | 1 | 2012 | 2136 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 3413 | 0.060 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 301 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1601 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2017 | 417 | 0.060 |
Why?
|
| Live Birth | 1 | 2025 | 64 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2025 | 732 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2025 | 29 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2025 | 42 | 0.060 |
Why?
|
| Acetylation | 1 | 2025 | 182 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2025 | 151 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2011 | 950 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2020 | 12891 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 1076 | 0.050 |
Why?
|
| Receptors, CCR7 | 1 | 2024 | 21 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2005 | 705 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 752 | 0.050 |
Why?
|
| Middle Aged | 4 | 2021 | 28448 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4701 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2025 | 294 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 3 | 0.050 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2022 | 5 | 0.050 |
Why?
|
| Telencephalon | 1 | 2022 | 11 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 106 | 0.050 |
Why?
|
| Histone Demethylases | 1 | 2022 | 43 | 0.050 |
Why?
|
| Transfection | 2 | 2015 | 947 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1592 | 0.050 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2025 | 280 | 0.040 |
Why?
|
| T-Box Domain Proteins | 1 | 2022 | 120 | 0.040 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 788 | 0.040 |
Why?
|
| Cholesterol | 1 | 2024 | 540 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 219 | 0.040 |
Why?
|
| PAX6 Transcription Factor | 1 | 2020 | 37 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 243 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 517 | 0.040 |
Why?
|
| Aged | 2 | 2017 | 20925 | 0.040 |
Why?
|
| Transcription Factor HES-1 | 1 | 2019 | 17 | 0.040 |
Why?
|
| MyoD Protein | 1 | 2019 | 22 | 0.040 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Oncogenes | 1 | 2020 | 163 | 0.040 |
Why?
|
| Lysine | 1 | 2020 | 166 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2022 | 403 | 0.040 |
Why?
|
| B7 Antigens | 1 | 2019 | 15 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 92 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2019 | 101 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 105 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 116 | 0.040 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2018 | 15 | 0.040 |
Why?
|
| Annexin A5 | 1 | 2018 | 18 | 0.040 |
Why?
|
| Registries | 1 | 2025 | 1594 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 27 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 378 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2019 | 234 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2022 | 771 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2018 | 63 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 284 | 0.030 |
Why?
|
| Cytokines | 1 | 2024 | 1341 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 2017 | 32 | 0.030 |
Why?
|
| Inflammation | 1 | 2025 | 1489 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2018 | 99 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 274 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2018 | 167 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 663 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 358 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 193 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2017 | 93 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 358 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2025 | 3835 | 0.030 |
Why?
|
| Phenotype | 2 | 2017 | 4479 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 153 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2025 | 5221 | 0.030 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2016 | 16 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1509 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 978 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 630 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 564 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2571 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2018 | 456 | 0.030 |
Why?
|
| Craniospinal Irradiation | 1 | 2016 | 60 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 1791 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2018 | 1060 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1486 | 0.030 |
Why?
|
| Plicamycin | 1 | 2014 | 4 | 0.030 |
Why?
|
| Patched Receptors | 1 | 2014 | 27 | 0.030 |
Why?
|
| Drug Design | 1 | 2015 | 162 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1214 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 52 | 0.030 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2021 | 1558 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 492 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2014 | 111 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2013 | 59 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 772 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 915 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 249 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 1305 | 0.020 |
Why?
|
| Disease Management | 1 | 2016 | 562 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2013 | 417 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2025 | 8553 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 431 | 0.020 |
Why?
|
| Protein Phosphatase 2C | 1 | 2012 | 59 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 300 | 0.020 |
Why?
|
| Endpoint Determination | 1 | 2011 | 57 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2012 | 413 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 10993 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1622 | 0.020 |
Why?
|
| Methylation | 1 | 2010 | 197 | 0.020 |
Why?
|
| Intellectual Property | 1 | 2010 | 9 | 0.020 |
Why?
|
| Brain | 1 | 2022 | 3189 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 848 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1010 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 200 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 165 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2011 | 251 | 0.020 |
Why?
|
| United States | 1 | 2025 | 11820 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3487 | 0.020 |
Why?
|
| Point Mutation | 1 | 2010 | 332 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2011 | 533 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 576 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 1228 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3844 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1214 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2849 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 5085 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1006 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2010 | 506 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2011 | 1342 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 6773 | 0.010 |
Why?
|
| Echocardiography | 1 | 2011 | 1135 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 1728 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 941 | 0.010 |
Why?
|
| Hypertension | 1 | 2011 | 1356 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 17653 | 0.010 |
Why?
|